Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

“…The addition of ArNO to 2 equiv of [Me₂NN]Ni(2,4-lutidine) {[Me₂NN]⁻ = 2,4-bis(2,6-dimethylphenylimido)pentyl} gives {[Me₂NN]Ni}₂(μ-η²:η²-ONAr) (<b>1a</b> and <b>1b</b>), which exhibit symmetrical bonding of the ArNO moiety between two [Me₂NN]Ni fragments, with a N−O bond distance of 1.440(4) Å in <b>1a</b> that is significantly longer than those in free <i>C</i>-organonitroso compounds (1.13−1.29 Å). …”

Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

“…The addition of ArNO to 2 equiv of [Me₂NN]Ni(2,4-lutidine) {[Me₂NN]⁻ = 2,4-bis(2,6-dimethylphenylimido)pentyl} gives {[Me₂NN]Ni}₂(μ-η²:η²-ONAr) (<b>1a</b> and <b>1b</b>), which exhibit symmetrical bonding of the ArNO moiety between two [Me₂NN]Ni fragments, with a N−O bond distance of 1.440(4) Å in <b>1a</b> that is significantly longer than those in free <i>C</i>-organonitroso compounds (1.13−1.29 Å). …”

Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

“…The addition of ArNO to 2 equiv of [Me₂NN]Ni(2,4-lutidine) {[Me₂NN]⁻ = 2,4-bis(2,6-dimethylphenylimido)pentyl} gives {[Me₂NN]Ni}₂(μ-η²:η²-ONAr) (<b>1a</b> and <b>1b</b>), which exhibit symmetrical bonding of the ArNO moiety between two [Me₂NN]Ni fragments, with a N−O bond distance of 1.440(4) Å in <b>1a</b> that is significantly longer than those in free <i>C</i>-organonitroso compounds (1.13−1.29 Å). …”

N2142A mutation reduced viral replication and binding to cell by impairing receptor binding. by Xue Li (285380)

“…Fold decrease (prefixed with a minus sign) in viral titer is also shown. …”

A 50-year-old female patient with diffuse PTL. by Yu Xia (8822)

Log2 fold changes in control and ATRX knockdown HFFs upon IFN-β stimulation. by Anne-Charlotte Stilp (3520415)

Climate by vegetation. by Dawn Robin Magness (6157265)

Genes showing ≥3-fold changes in expression in IgG4-RD patients in response to steroid therapy. by Akio Nakajima (301253)

Genes showing ≥3-fold differences in expression level in IgG4-RD patients and healthy controls. by Akio Nakajima (301253)

“…<p>We identified 21 genes showing a ≥3-fold increase (16 genes) or decrease (5genes) in expression level among 4 samples from 4 healthy controls and 2 IgG4-RD patients before and after therapy.…”

Performances of the three machine learning models based on ten-fold cross-validation and walk-forward validation: Multiple linear regression (MLR), random forest (RF), and a deep n... by Yingjie Hu (1579000)

Assessment of intratumoral CD3+ and CD8+ lymphocyte populations. by Gerik W. Tushoski-Alemán (17951809)

Modeled lichen species richness in a prediction grid from 0 to 4000 m from the DMTS haul road in Cape Krusenstern National Monument, Alaska. by Peter N. Neitlich (4034300)

Subjects:

LPS up-regulated DEGs identified by RRA and fold-change analysis. by Giorgia Colombo (6337118)

P-Rex is required for a late phase of stimulus-evoked cerebellar LTP. by Claire Jackson (362873)

Top 50 up-regulated genes in <i>lin-35(n745</i>), mutant in starved L1 animals. by Ashwin Seetharaman (615458)

Intraperitoneal administration with streptavidin benefits an establishment of a CD-1 mice model for <i>P</i>. <i>aeruginosa</i>, of which the plasma (and organ contents) biotin lev... by Yu Shi (117923)

Inhibition and assessment of the biophysical gating properties of GluA2 and GluA2/A3 AMPA receptors using curcumin derivatives by Mohammad Qneibi (7314050)

“…The biophysical parameter (i.e., desensitization, deactivation, and peak currents) were measured by using whole-cell patch clamp electrophysiology with and without the administration of the derivatives onto HEK293 cells. CR-NN, CR-NNPh, CR-MeNH, and CR-NO of the tested derivatives showed inhibition on all AMPA receptors up to 6 folds. …”

IC₅₀s data of antimalarials against controls. by Winnie Okore (14139712)

Heatmap of fold-changes of metabolites. by Elena Heidenreich (6940475)

“…A) Metabolite fold-change per cell, B) Metabolite fold-change per POC.…”

Stop-programmable folding principle. by Antoine Legrain (741174)

“…<p>The design of the complex hinges is such that once folded, the flap forms a predefined angle with the planar support. …”